Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: A randomised cross-over study

Lancet

Volumn 359, Issue 9324, 2002, Pages 2145-2152

  Vadhan Raj, Saroj ^a,c   Kavanagh, John J ^a   Freedman, Ralph S ^a   Folloder, Jody ^a   Currie, Laura M ^b   Bueso Ramos, Carlos ^a   Verschraegen, Claire F ^a   Narvios, Aida B ^a   Connor, Jerome ^b   Hoots, William K ^a   Broemeling, Lyle D ^a   Lichtiger, Benjamin ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b LIFECELL CORPORATION   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; DIMETHYL SULFOXIDE; PRESERVATIVE; RECOMBINANT THROMBOPOIETIN;

ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD TRANSFUSION REACTION; BODY SURFACE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CRYOPRESERVATION; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; GYNECOLOGIC CANCER; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAFETY; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOCYTOPHERESIS; TREATMENT OUTCOME;

EID: 0037157612     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)09090-6     Document Type: Article

References (34)

1. Principles of platelet transfusion therapy
2. Current issues with platelet transfusion in patients with cancer
3. Collection and transfusion of blood and blood components in the United States, 1992
4. Collection and transfusion of blood and blood components in the United States
5. Analysis of utilization and cost of platelet transfusions in refractory hematology/oncology patients
6. The perils of platelet transfusions
7. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions
8. Thrombopoietin: The primary regulator of platelet production
9. Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer
10. Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer
11. Transfusion experience with platelet concentrates stored for 24 to 72 hours at 22°C
12. Platelet storage for transfusion
13. Clinical experience with transfusion of cryopreserved platelets
14. Frozen autologous platelet transfusion for patients with leukemia
15. Autologous platelet collection and storage to support thrombocytopenia in patients undergoing high-dose chemotherapy and circulating progenitor cell transplantation for high-risk breast cancer
16. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer
17. Morphological and functional disturbances of platelets induced by cryopreservation
18. Cryopreservation of human platelets with dimethyl sulfoxide: Changes in biochemistry and cell function
19. Recovery of in vitro functional activity of platelet concentrates stored at 4 C and treated with second-messenger effectors
20. Cryopreservation of single donor platelets with a reduced dimethyl sulfoxide concentration by the addition of second messenger effectors: Enhanced retention of in vitro functional activity
21. Enhanced retention of in vitro functional activity of platelets from recombinant human thrombopoietin-treated patients following long-term cryopreservation with a platelet-preserving solution (ThromboSol) and 2% DMSO
22. Prevention and management of platelet transfusion refractoriness
23. The definition of refractoriness to platelet transfusions
24. Carboplatin dosage: Prospective evaluation of a simple formula based on renal function
25. Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin
26. Thrombopoietin therapy increases platelet yields in healthy platelet donors
27. Storage and quality assessment of platelets
28. Enhanced circulatory parameters of human platelets cryopreserved with second-messenger effectors: An in vivo study of 16 volunteer platelet donors
29. Summary of a workshop on in vivo efficacy of transfused platelet components and platelet substitutes
30. Leukocyte depletion of random single-donor platelet transfusions does not prevent secondary human leukocyte antigen-alloimmunization and refractoriness: A randomized prospective study
31. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization: A prospective, randomized trial
32. Platelet refractoriness and alloimunization in pediatric oncology and bone marrow transplant patients